Acceleration of bone formation using in situ-formed hyaluronan-hydrogel containing bone morphogenetic protein-2 in a mouse critical size bone defect model

Biomed Mater Eng. 2021;32(4):207-215. doi: 10.3233/BME-201172.

Abstract

Background: An enzymatic crosslinking strategy using hydrogen peroxide and horseradish peroxidase is receiving increasing attention for application with in situ-formed hydrogels (IFHGs). IFHGs may also be ideal carrier materials for bone repair, although their ability to carry bone morphogenetic protein-2 (BMP2) has yet to be examined.

Objective: We examined the effectiveness of an IFHG made of hyaluronan (IFHG-HA) containing BMP2 for promoting bone formation in a mouse critical size bone defect model.

Methods: C57/BL6J mice received a 2-mm femoral critical-sized bone defect before being randomly assigned to one of the following treatment groups (n = 6): control (no treatment), IFHG-HA only, PBS with BMP2, and IFHG-HA with BMP2. X-ray radiographs were utilized to track new bone formation, and micro-computed tomography and histological examination were performed on new bone formed at the bone defect site two weeks after surgery.

Results: Mice treated with PBS with BMP2 and IFHG-HA with BMP2 had greater bone volume (BV) and bone mineral content (BMC) than those receiving control, and successfully achieved consolidation. Mice treated with IFHG-HA with BMP2 had significantly higher BV and BMC than those treated with PBS with BMP2.

Conclusions: IFHG-HA may be an effective carrier for BMP2 to enable delivery for bone defect repair.

Keywords: In situ-formed hydrogels; bone defect; bone morphogenetic protein-2; carrier.

MeSH terms

  • Acceleration
  • Animals
  • Bone Morphogenetic Protein 2
  • Hyaluronic Acid
  • Hydrogels*
  • Mice
  • Osteogenesis*
  • Skull
  • X-Ray Microtomography

Substances

  • Bone Morphogenetic Protein 2
  • Hydrogels
  • Hyaluronic Acid